Fluorescent Cholangiography vs White Light for Bile Ducts Identification

NCT02702843 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 677

Last updated 2025-11-12

Study results available
· View outcomes & findings →

Summary

The Study is designed to compare the effectiveness of Near Infrared Fluorescence Cholangiography (NIFC) to standard white light imaging (WLI) in visualizing and identifying the main biliary and hepatic structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction and any Accessory Ducts) during laparoscopic cholecystectomy. The aim is to demonstrate that NIFC performs better than standard white light (WLI) alone in visualizing and identifying extra-hepatobiliary structures (Cystic Duct, Right Hepatic Duct, Common Hepatic Duct, Common Bile Duct, Cystic-CBD junction, Cystic-Gallbladder junction, and any Accessory Ducts) before and after dissection during Laparoscopic Cholecystectomy (LC).

Conditions

Interventions

PROCEDURE

Laparoscopic cholecystectomy with Xenon light

Standard laparoscopic cholecystectomy with white light

PROCEDURE

Laparoscopic cholecystectomy (fluorescent cholangiography)

Laparoscopic cholecystectomy in infrared light after injection of indocyanine green pre-operatively.

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    collaborator OTHER
  • Tokyo Medical University

    collaborator OTHER
  • Asklepios Kliniken Hamburg GmbH

    collaborator OTHER
  • Università degli Studi dell'Insubria

    collaborator OTHER
  • University of Rostock

    collaborator OTHER
  • Hospital de Clinicas José de San Martín

    collaborator OTHER
  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Raul Rosenthal, MD · Cleveland Clinic Florida

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-12-31
Completion
2018-08-31

Countries

  • United States
  • Argentina
  • Germany
  • Italy
  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02702843 on ClinicalTrials.gov